Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients

This study has been terminated.
(In January, 2013 Merck had decided to take steps to suspend the availability of TREDAPTIVE globally)
Information provided by (Responsible Party):
Sheba Medical Center Identifier:
First received: January 16, 2010
Last updated: April 21, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)